Clinical Trial

Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision

Recruiting
View on ClinicalTrials.gov →
Summary
Congenital melanocytic nevi (CMN) are a quite common congenital disorder. Over years, surgical excision was proposed to the patients because transformation into a malignant skin tumor (melanoma) was feared. Recent data proof that the risk for malignancy was overestimated. Nowadays still a lot of patients express their wish for surgical removal out of aesthetic reasons and psychological impacts. Many patients and families experience stigmatization because of the nevus. To proof a medical indication for surgical removal the investigators want to evaluate the quality of life and stigmatization before and after nevus surgery.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2014-10-31; most recent amendment 2026-03-02.
Trial Details
NCT Number NCT02280889
Lead Sponsor University Children's Hospital, Zurich
Conditions Quality of Life, Stigmatization
Enrollment 100 participants
Start Date 2013-05
Primary Completion 2031-12 (estimated)
Study Completion 2031-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-04